These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15623576)

  • 1. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.
    Tscharke DC; Karupiah G; Zhou J; Palmore T; Irvine KR; Haeryfar SM; Williams S; Sidney J; Sette A; Bennink JR; Yewdell JW
    J Exp Med; 2005 Jan; 201(1):95-104. PubMed ID: 15623576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
    Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.
    Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA
    Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus.
    Flesch IE; Hollett NA; Wong YC; Quinan BR; Howard D; da Fonseca FG; Tscharke DC
    J Immunol; 2015 Sep; 195(5):2263-72. PubMed ID: 26195812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
    McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
    J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model.
    Kumar A; Suryadevara NC; Wolf KJ; Wilson JT; Di Paolo RJ; Brien JD; Joyce S
    Sci Rep; 2020 Aug; 10(1):13167. PubMed ID: 32759969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
    Kremer M; Suezer Y; Volz A; Frenz T; Majzoub M; Hanschmann KM; Lehmann MH; Kalinke U; Sutter G
    PLoS Pathog; 2012; 8(3):e1002557. PubMed ID: 22396645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
    Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
    J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.
    Green S; Ennis FA; Mathew A
    Vaccine; 2011 Feb; 29(8):1666-76. PubMed ID: 21195803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
    Terajima M; Cruz J; Raines G; Kilpatrick ED; Kennedy JS; Rothman AL; Ennis FA
    J Exp Med; 2003 Apr; 197(7):927-32. PubMed ID: 12668642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
    Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
    Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.
    Walsh SR; Gillis J; Peters B; Mothé BR; Sidney J; Sette A; Johnson RP
    Vaccine; 2009 Aug; 27(36):4990-5000. PubMed ID: 19531389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.
    Oseroff C; Peters B; Pasquetto V; Moutaftsi M; Sidney J; Panchanathan V; Tscharke DC; Maillere B; Grey H; Sette A
    J Immunol; 2008 Jun; 180(11):7193-202. PubMed ID: 18490718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodomination during peripheral vaccinia virus infection.
    Lin LC; Flesch IE; Tscharke DC
    PLoS Pathog; 2013; 9(4):e1003329. PubMed ID: 23633956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified-vaccinia-virus-Ankara (MVA) priming and fowlpox-virus booster elicit a stronger CD8+ T-cell response in mice against an HIV-1 epitope than does a DNA/poxvirus prime-booster approach.
    Vázquez-Blomquist D; Quintana D; Duarte CA
    Biotechnol Appl Biochem; 2004 Jun; 39(Pt 3):313-8. PubMed ID: 15154843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.